PRESS RELEASE published on 07/01/2024 at 09:00, 1 year 5 months ago Biotest prepares launch of its immunoglobulin Yimmugo in the USA, establishing a framework for a strategic billion-dollar distribution agreement with Kedrion Biotest AG is set to launch its immunoglobulin Yimmugo in the USA with a strategic billion-dollar agreement with Kedrion, following FDA approval. The distribution deal aims to generate over $1 billion in revenue for Biotest Biotest AG Yimmugo Immunoglobulin USA Market Launch Strategic Agreement
BRIEF published on 06/24/2024 at 14:05, 1 year 5 months ago Biotest's GoFuture Campaign Featured in Documentary "Future Seeds" Sustainability Biotest AG GoFuture Future Seeds Eco-anxiety
BRIEF published on 06/24/2024 at 14:05, 1 year 5 months ago La campagne GoFuture de Biotest présentée dans le documentaire « Future Seeds » Durabilité Biotest SA Aller Au Futur Semences Du Futur Éco-anxiété
PRESS RELEASE published on 06/24/2024 at 14:00, 1 year 5 months ago Biotest's sustainability campaign GoFuture part of the new documentary 'Future Seeds' Biotest AG's sustainability campaign GoFuture featured in the documentary 'Future Seeds', now available on Prime Video in twelve countries Documentary Biotest AG GoFuture Future Seeds Sustainability Campaign
BRIEF published on 06/17/2024 at 09:05, 1 year 5 months ago Biotest Achieves Milestone with FDA Approval for Yimmugo FDA Approval Yimmugo Biotest Immunodeficiencies Next Level Facility
BRIEF published on 06/17/2024 at 09:05, 1 year 5 months ago Biotest franchit une étape importante avec l'approbation de la FDA pour Yimmugo Approbation De La FDA Yimmugo Biotest Immunodéficiences Installation De Niveau Supérieur
PRESS RELEASE published on 06/17/2024 at 09:00, 1 year 5 months ago Milestone for Biotest: US approval for innovative immunoglobulin Yimmugo Biotest AG achieves US approval for intravenous immunoglobulin Yimmugo, marking a significant milestone and future sales growth in the global market Healthcare Innovation Biotest AG FDA Certification US Approval Immunoglobulin Yimmugo
BRIEF published on 05/07/2024 at 20:31, 1 year 6 months ago Biotest AG: Dividend Approval at Annual General Meeting Annual General Meeting Shareholder Approval Dividend Distribution Preference Shares Biotest AG
BRIEF published on 05/07/2024 at 20:31, 1 year 6 months ago Biotest AG : approbation du dividende lors de l'assemblée générale annuelle Assemblée Générale Annuelle Approbation Des Actionnaires Répartition Des Dividendes Partage De Préférence Biotest SA
PRESS RELEASE published on 05/07/2024 at 20:26, 1 year 6 months ago Biotest AG: Annual General Meeting approves dividend distribution Biotest AG's Annual General Meeting approves dividend distribution of EUR 0.04 per preference share for 2023 and 2022, with majority support. CEO Peter Janssen's speech available online Annual General Meeting Shareholders Dividend Distribution Biotest AG Peter Janssen
Published on 12/05/2025 at 20:25, 17 minutes ago The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others
Published on 12/05/2025 at 20:15, 27 minutes ago When Proof Becomes Infrastructure, Markets Rewrite the Story (NASDAQ: SMX)
Published on 12/05/2025 at 19:50, 52 minutes ago Gold, Rare Earth Minerals, Digital Assets: The Market Just Realized SMX Sits in All Three
Published on 12/05/2025 at 19:20, 1 hour 22 minutes ago The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 1 hour 57 minutes ago Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:58, 1 hour 44 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 2 hours 26 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 2 hours 56 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:18, 3 hours 24 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 3 hours 24 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 5 hours 31 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 5 hours 31 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 6 hours 43 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
